Literature DB >> 20014057

Depression and major depressive disorder in patients with Parkinson's disease.

Takeshi Inoue1, Mayumi Kitagawa, Teruaki Tanaka, Shin Nakagawa, Tsukasa Koyama.   

Abstract

The prevalence of depression in Parkinson's disease (PD) varies greatly. In this study, we investigated major depressive disorder (MDD) and depressive symptoms without MDD in patients with PD. The psychopathological characteristics of depressive symptoms were assessed by a psychiatric interview. A total of 105 Japanese patients with PD without dementia were included. The Japanese version of the Beck Depression Inventory-II (BDI-II) with a cutoff score of 13/14 was used to screen for depression. Using a structured interview, a comprehensive psychiatric evaluation of patients with BDI-II scores >13 (high BDI patients) was completed using the criteria of the Diagnostic and Statistical Manual of Mental Disorders (DSM)-IV-TR. Forty patients (38%) had a BDI-II >13, but 29 did not show any depressed mood. Five cases met the criteria for MDD (three current, two past) and one patient was diagnosed with minor depressive disorder. A slight depressed mood that was associated with worrying about PD was seen in 6 of 34 patients without any depressive disorder and fluctuated with aggravation of PD symptoms in two of these patients. For the diagnosis of MDD, the number of positive items from the DSM-IV-TR definition of MDD is most important and useful for differentiating MDD and non-MDD. The low-prevalence rate of MDD in our patient population suggests that PD may be a psychological stressor for MDD, but does not necessarily induce MDD.

Entities:  

Mesh:

Year:  2010        PMID: 20014057     DOI: 10.1002/mds.22921

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  9 in total

1.  Assessing depression and factors possibly associated with depression during the course of Parkinson's disease.

Authors:  Amy H Farabaugh; Joseph J Locascio; Liang Yap; Maurizio Fava; Stella Bitran; Jessica L Sousa; John H Growdon
Journal:  Ann Clin Psychiatry       Date:  2011-08       Impact factor: 1.567

2.  Neurologist-associated reduction in PD-related hospitalizations and health care expenditures.

Authors:  Allison W Willis; Mario Schootman; Rebecca Tran; Nathan Kung; Bradley A Evanoff; Joel S Perlmutter; Brad A Racette
Journal:  Neurology       Date:  2012-10-10       Impact factor: 9.910

3.  Suicidal behavior in prodromal Huntington disease.

Authors:  Jess G Fiedorowicz; James A Mills; Adam Ruggle; Douglas Langbehn; Jane S Paulsen
Journal:  Neurodegener Dis       Date:  2011-06-09       Impact factor: 2.977

4.  Effect of high-frequency repetitive transcranial magnetic stimulation on major depressive disorder in patients with Parkinson's disease.

Authors:  Hae-Won Shin; Young C Youn; Sun J Chung; Young H Sohn
Journal:  J Neurol       Date:  2016-05-13       Impact factor: 4.849

5.  Major depressive disorder in Parkinson's disease: a cross-sectional study from Sri Lanka.

Authors:  Tharini Ketharanathan; Raveen Hanwella; Rajiv Weerasundera; Varuni A de Silva
Journal:  BMC Psychiatry       Date:  2014-09-30       Impact factor: 3.630

6.  Reconsidering Animal Models of Major Depressive Disorder in the Elderly.

Authors:  Shigenobu Toda; Yoshio Iguchi; Ziqiao Lin; Hiromi Nishikawa; Tatsuya Nagasawa; Hirotaka Watanabe; Yoshio Minabe
Journal:  Front Aging Neurosci       Date:  2016-08-08       Impact factor: 5.750

7.  Clinical Features of Parkinson's Disease in Patients with Early-Onset Freezing of Gait.

Authors:  Hiroo Terashi; Yuki Ueta; Takeshi Taguchi; Hiroshi Mitoma; Hitoshi Aizawa
Journal:  Parkinsons Dis       Date:  2022-07-08

8.  Protocol of a randomised delayed-start double-blind placebo-controlled multi-centre trial for Levodopa in EArly Parkinson's disease: the LEAP-study.

Authors:  Constant V M Verschuur; S R Suwijn; B Post; M Dijkgraaf; B R Bloem; J J van Hilten; T van Laar; G Tissingh; G Deuschl; A E Lang; R J de Haan; R M A de Bie
Journal:  BMC Neurol       Date:  2015-11-19       Impact factor: 2.474

9.  The efficacy of combined music therapy and Tai Chi for major depressive disorder: Study protocol for a randomized controlled trial.

Authors:  Huixian Xie; Yiping Tang; Fengmin Cheng; Jucai Chu
Journal:  Medicine (Baltimore)       Date:  2021-03-26       Impact factor: 1.817

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.